arrow
J

José Manuel Reyes-Ruíz

Instituto Mexicano del Seguro Social
H指数:17
被引数:1,062

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA)

网络驱动的抗病毒发现流程用于新兴RNA病毒:来自墨西哥抗病毒发展网络(RMDA)的批判性视角

2026-08-140
OAAI
Small extracellular vesicles from DENV2-infected C6/36 cells show viral infection in vitro and in vivo
2026-01-270
OA
Fisetin as an Antiviral Agent Targeting the RNA-Dependent RNA Polymerase of SARS-CoV-2: Computational Prediction and In Vitro Experimental Validation

Fisetin作为一种靶向SARS-CoV-2 RNA依赖性RNA聚合酶的抗病毒剂:计算预测与体外实验验证

2025-12-100
OAAI
The protective role of metformin against severe dengue disease in patients with type 2 diabetes mellitus: a preliminary report in Mexico
2025-11-010
PRE
Assessment of mortality risk by respiratory rate-specific quartiles in mechanically ventilated patients with acute respiratory distress syndrome in Mexico

通过呼吸频率特定四分位数对墨西哥机械通气急性呼吸窘迫综合征患者的死亡风险进行评估

2025-09-150
PRE
Antiviral effect of metformin and phenformin analogs against dengue in Huh-7 cells and AG129 mice

二甲双胍和苯乙双胍类似物对登革病毒的抗病毒作用(在Huh-7细胞和AG129小鼠中)

2025-08-230
PREAI
Advances and Challenges in Antiviral Development for Respiratory Viruses
2024-12-310
OAAI
Antiviral Effect of Microalgae Phaeodactylum tricornutum Protein Hydrolysates against Dengue Virus Serotype 2
2024-08-141
OAAI
Association between lipid profile and clinical outcomes in COVID-19 patients

新型冠状病毒肺炎患者血脂与临床结局的关系

2024-05-277
OAAI
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin

针对新型冠状病毒肺炎的双重药理学策略: 二甲双胍和阿托伐他汀的治疗潜力

2024-02-135
OAAI